Cargando…

Hypercalcemia during renal replacement therapy after liver transplantation

Detalles Bibliográficos
Autores principales:	Matsumi, J, Morimatsu, H, Morita, K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061743/ http://dx.doi.org/10.1186/cc9533

Ejemplares similares

Previous renal support is a predictor for chronic renal replacement therapy after orthotopic liver transplantation
por: Andreoli, MCC, et al.
Publicado: (2011)

Bilirubin and carboxy-hemoglobin concentrations in critically ill patients: prognostic significance of free heme metabolites
por: Morimatsu, H, et al.
Publicado: (2011)

Two cases of variceal haemorrhage during living-donor liver transplantation
por: Matsusaki, T., et al.
Publicado: (2011)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Requirement for renal replacement therapy following orthotopic liver transplantation in adults is associated with prolonged mechanical ventilation and higher incidence of pneumonia
por: Bearfield, P, et al.
Publicado: (2008)

Incidence and outcome of acute renal failure necessitating renal replacement therapy after trauma
por: Beitland, S, et al.
Publicado: (2009)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Association between type of anticoagulation and blood transfusion requirements during renal replacement therapy in the ICU
por: Iyer, A, et al.
Publicado: (2011)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Renal replacement therapy in very elderly critical care patients
por: Brown, K, et al.
Publicado: (2014)

Bacteremia, APACHE II and need for renal replacement therapy are independent predictors of mortality in critically ill transplanted patients with cirrhosis
por: Karvellas, C, et al.
Publicado: (2010)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Fluid balance and renal outcomes in patients requiring renal replacement therapy in the ICU
por: Silversides, JA, et al.
Publicado: (2013)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Serum tobramycin levels during selective decontamination of the digestive tract in ICU patients on renal replacement therapy
por: Mol, M, et al.
Publicado: (2008)

Influence of veno-venous renal replacement therapy on transpulmonary thermodilution measurements
por: Sakka, S, et al.
Publicado: (2006)

A RIFLE score-based trigger for renal replacement therapy and survival after cardiac surgery
por: Schneider, A, et al.
Publicado: (2012)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Micronutrient loss in renal replacement therapy for acute kidney injury
por: Oh, W, et al.
Publicado: (2015)

An audit of antibiotic dosing according to renal function or renal replacement therapy in critical care
por: Donnelly, KD, et al.
Publicado: (2011)

Fluid accumulation post cardiac surgery and risk for renal replacement therapy
por: Moore, EM, et al.
Publicado: (2014)

Outcome of patients treated with renal replacement therapy for acute kidney injury
por: Desegher, A, et al.
Publicado: (2006)

Systemic citrate load during continuous renal replacement therapy is not negligible and can be predicted using indirect methods
por: Zakharchenko, M, et al.
Publicado: (2011)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Insulin-like growth factor-1 during renal replacement therapy in patients with multiple organ failure
por: Yakovleva, I, et al.
Publicado: (2005)

Infection in ICU patients with acute kidney injury treated with renal replacement therapy
por: Reynvoet, E, et al.
Publicado: (2006)

Renal replacement therapy and bloodstream infections in cardiovascular intensive care patients
por: Strabelli, TMV, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3qgms18mqpib8gea5pfrh789jh